Narrow spectrum kinase inhibitors demonstrate promise for the treatment of dry eye disease and other ocular inflammatory disorders

Suzanne Hagan, Matthew C.T. Fyfe, Boatemaa Ofori-Frimpong, Katherine Oliver, Martyn R. Foster, Sameer Sirohi, Yemisi Solanke, Michael Doughty, Adele Rowley, Mike Taylor, Steve Webber, Claire A. Walshe*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

93 Downloads (Pure)

Fingerprint Dive into the research topics of 'Narrow spectrum kinase inhibitors demonstrate promise for the treatment of dry eye disease and other ocular inflammatory disorders'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences